Cargando…
Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
Dyslipidemia and resulting lipotoxicity are pathologic signatures of metabolic syndrome and type 2 diabetes. Excess lipid causes cell dysfunction and induces cell death through pleiotropic mechanisms that link to oxidative stress. However, pathways that regulate the response to metabolic stress are...
Autores principales: | Sletten, Arthur C., Davidson, Jessica W., Yagabasan, Busra, Moores, Samantha, Schwaiger-Haber, Michaela, Fujiwara, Hideji, Gale, Sarah, Jiang, Xuntian, Sidhu, Rohini, Gelman, Susan J., Zhao, Shuang, Patti, Gary J., Ory, Daniel S., Schaffer, Jean E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410784/ https://www.ncbi.nlm.nih.gov/pubmed/34471131 http://dx.doi.org/10.1038/s41467-021-25457-y |
Ejemplares similares
-
Author Correction: Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
por: Sletten, Arthur C., et al.
Publicado: (2021) -
SNORA73B promotes endometrial cancer progression through targeting
MIB1
and regulating host gene RCC1 alternative splicing
por: Chen, Xi, et al.
Publicado: (2023) -
A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid
por: Sidhu, Rohini, et al.
Publicado: (2015) -
What is the Role of SNORA42 in Carcinogenesis? A Systematic Review
por: Barbosa, Eldevan da Silva, et al.
Publicado: (2023) -
SNORA21 – An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer
por: Yoshida, Kazuhiro, et al.
Publicado: (2017)